About Morepen RX Limited
Data last updated:
Morepen RX Limited is a public limited company based in Nalagarh, Himachal Pradesh, India, a subsidiary of Morepen Laboratories Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 March 2023.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U21001HP2023PLC009940. Its GSTIN is 07AAQCM6471Q1ZG (Delhi). The company holds 12 GST registrations, all of them active.
The company has an authorised share capital of ₹8 Cr and a paid-up capital of ₹7.08 Cr. It is led by directors including Varun Suri (Whole-Time Director) and Sanjay Suri.
Its last annual general meeting (AGM) was held on 06 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Village Morepen, Nalagarh Road Near Baddi, Himachal Pradesh, India – 173205.
As per the financials filed for FY 2025, the company reported a revenue of ₹112.79 Cr, a growth of 35% compared to the previous year. For the same year it recorded a net profit of ₹18.4 Lakh (net margin 0.2%) and EBITDA of ₹1.47 Cr (EBITDA margin 1.3%).
Court records list 16 cases involving the company, including 15 filed by the company and 1 filed against it; 10 cases are pending.
For more details, the company can be reached via its website morepen.com.
Company details
Contact details
Morepen RX Limited's registered office is in Nalagarh, Himachal Pradesh. Its website is morepen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressVillage Morepen, Nalagarh Road Near Baddi, Himachal Pradesh, India – 173205
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Morepen RX Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Morepen RX is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Morepen RX Limited, buy the company report.
Financials of Morepen RX Limited
FY 2025 filings availableMorepen RX Limited reported revenue of ₹112.79 Cr (up 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 35% in the latest year. EBITDA rose 126% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹1.47 Cr | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹18.4 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.3% | ||
| Net Profit Margin | 0.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Morepen RX Limited, buy the company report.
Board of directors of Morepen RX Limited
Morepen RX has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Varun Suri Also directs: Bliss & Blue Ventures LLP, Happier Life Private Limited, Morepen Hospitality Limited and 5 more | Whole-Time Director | 17 Mar 2023 | 3 Years 7 Months | Current |
| Sanjay Suri Also directs: Bliss & Blue Ventures LLP, Morepen Laboratories Limited, Morepen Proprietary Drug Research Private Limited and 5 more | Director | 17 Mar 2023 | 3 Years 7 Months | Current |
| Shalu Suri Also directs: Morepen Proprietary Drug Research Private Limited, Morepen Bio Limited, Silverring Drinks Private Limited and 5 more | Director | 17 Mar 2023 | 3 Years 7 Months | Current |
Peer comparison
Morepen RX Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vasu Organics Private Limited | ₹115.97 Cr (FY 2025) | 19.0% | Hyderabad, Telangana, India | |||
| Eppion Lifesciences Private Limited | ₹113.59 Cr (FY 2025) | 13.0% | New Delhi, Delhi, India | |||
| Concept Biosciences India Private Limited | ₹113.59 Cr (FY 2019) | 15.0% | Howrah, West Bengal, India | |||
| Dalvkot Utility Enterprises Private Limited | ₹112.96 Cr (FY 2024) | 25.0% | Bangalore, Karnataka, India | |||
| Morepen RX Limitedthis company | ₹112.79 Cr (FY 2025) | ₹18.4 Lakh | 0.2% | 35.0% | Nalagarh, Himachal Pradesh, India | |
| Greenspecialities Private Limited | ₹111.67 Cr (FY 2024) | 68.0% | Kochi, Kerala, India | |||
| Tricon Enterprises Private Limited | ₹111.48 Cr (FY 2025) | 32.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Morepen RX Limited, buy the company report.
Auditor
Morepen RX Limited is audited by Virender K Jain & Associates for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Virender K Jain & Associates | FY 2023 | 005994N |
Shareholding
The shareholding of Morepen RX Limited is on record for FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Morepen RX Limited, buy the company report.
Legal cases
Morepen RX Limited has 16 court cases on record: 15 filed by Morepen RX, 1 filed against it. 10 cases are pending and 6 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 16 | 1 | 10 |
Cases on record (5 of 16)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, New Delhi, Delhi | Civil suit | Filed by the company against M/S Atc Pharma Private Limited | Disposed |
| District court, Chamba, Himachal Pradesh | Court case (Drugs And Cosmetics Act) | Filed against the company | Pending |
| District court, New Delhi, Delhi | Civil suit | Filed by the company against M/S O P Pharma Distributor Pvt Ltd | Pending |
| District court, New Delhi, Delhi | Civil suit | Filed by the company against M/S Shri Jiwanda Ram Biotech | Pending |
| District court, New Delhi, Delhi | Civil suit | Filed by the company against M/S Allied Agencies | Pending |
To see the full case history of Morepen RX Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Morepen RX Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Morepen RX has 12 GST registrations: 12 active. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAQCM6471Q1ZG | Delhi | Active | 31 May 2023 |
| 06AAQCM6471Q1ZI | Haryana | Active | 28 Jun 2023 |
| 03AAQCM6471Q1ZO | Punjab | Active | 07 Jul 2023 |
| 23AAQCM6471Q1ZM | Madhya Pradesh | Active | 10 Jul 2023 |
To see the full GST registrations and return filing status of Morepen RX Limited, buy the company report.
Recent activity
Morepen RX Limited has 7 board changes on record since 2023: 7 appointments. The latest: Ajay Kumar Sharma was appointed as Non- Individual Subscriber on 17 Mar 2023.
News
Frequently asked questions
Morepen RX is an active public limited company based in Nalagarh, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 March 2023 (3+ years old) and is registered under CIN U21001HP2023PLC009940.
Morepen RX has 3 current directors:
- Varun Suri - Whole-Time Director
- Sanjay Suri - Director
- Shalu Suri - Director
The latest financial statements of Morepen RX on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 06 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Morepen RX is 07AAQCM6471Q1ZG, registered in Delhi. The company has 12 GST registrations in all, of which 12 are active. Other active GSTINs include 06AAQCM6471Q1ZI (Haryana), 03AAQCM6471Q1ZO (Punjab), 23AAQCM6471Q1ZM (Madhya Pradesh).
The CIN (Corporate Identification Number) of Morepen RX is U21001HP2023PLC009940. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Morepen RX has 16 court cases on record: 15 filed by the company and 1 filed against it. 10 are pending.
Morepen RX was incorporated on 17 March 2023, making it 3+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of Morepen RX by revenue are Vasu Organics Private Limited, Eppion Lifesciences Private Limited, Concept Biosciences India Private Limited, Dalvkot Utility Enterprises Private Limited, Greenspecialities Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Ajay Kumar Sharma was appointed as Non- Individual Subscriber on 17 Mar 2023. Anju Suri was appointed as Individual Subscriber on 17 Mar 2023. Kushal Suri was appointed as Individual Subscriber on 17 Mar 2023. Morepen RX has 7 board changes on record in total.
Morepen RX can be reached through the website morepen.com. Its registered office is in Nalagarh, Himachal Pradesh, India.
The registered office of Morepen RX is at Village Morepen, Nalagarh Road Near Baddi, Himachal Pradesh, India – 173205.